Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A ... - Reuters India

Reuters India

Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A ... Reuters India MUMBAI (Reuters) - Sun Pharmaceuticals Industries Ltd (SUN.NS), emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy ... and more »

from Top Stories - Google News http://ift.tt/1PQd57W
via IFTTT